Canada Talks Pharma: How Artificial Intelligence Is Transforming Clinical Trial Recruitment Toronto, May 15, 2018 at 9:30am Deep 6 AI presented at Canada Talks Pharma, “How Artificial Intelligence Is Transforming Clinical Trial Recruitment,” on May 15, at 9:30am in Toronto. [vc_row][vc_column width='2/3']Wout Brusselaers, CEO and co-founder of Deep 6 AI,...
Deep 6 demos at ACRP 2018 WASHINGTON, DC. (April 27, 2018) – We just had our first booth presence at the ACRP Expo 2018., a premier continuing education and networking event for clinical research professionals. With over 60 sessions and workshops designed to improve the quality...
Deep 6 discussed the ROI of AI for Clinical Trials at Bridging Clinical Research NATIONAL HARBOR, Maryland. (April 4, 2018) – Eric Gildenhuys, Deep 6 AI Vice President of Business Development, presented on "Creating Synergies Between Health Care and Clinical Trial Data Through Technology" at the 2018...
Wout Brusselaers to Speak at HIMSS18 on Finding the Return on Investment of Artificial Intelligence [caption id="attachment_17174" align="alignright" width="175"] Bobbie J Rimel, MD, Cedars-Sinai Medical Center[/caption] [caption id="attachment_17173" align="alignright" width="175"] Wout Brusselaers, CEO, Deep 6 AI[/caption] PASADENA, Calif. (February 13, 2018) – HIMSS has named Wout Brusselaers, chief...
Texas Medical Center selects Deep 6 AI for accelerator Deep 6 AI is one of 23 digital health startups participating in the Texas Medical Center Accelerator (TMCx). The Texas Medical Center is the world's largest medical center with 58 member institutions and a central research institute...
Deep 6 AI: highlights from our 2017 2017 was a whirlwind of activity for us at Deep 6 AI. Armed with lofty goals and insightful feedback from customers and industry experts, we were heads-down, elbows-deep in work as we continued to evolve our product and spread the...
Former IBM Watson Health Head of West Coast Sales Joins Deep 6 AI PASADENA, Calif. (October 19, 2017) – Former IBM Watson Health sales executive, Bill Hutchins, is joining Deep 6 AI to to support the rapid expansion of its clinical trial patient recruitment platform across...
TD2 and Deep 6 AI Announce Partnership to Accelerate Oncology Clinical Trial Recruitment Artificial intelligence used to identify potential clinical trial participants in minutes SCOTTSDALE, Ariz. and PASADENA, Calif. (May 31, 2017) – Translational Drug Development (TD2) and Deep 6 AI announced today a formal agreement to...
SXSW 2017: Big wins, great connections SXSW was a whirlwind of activity and opportunity for Deep 6 AI. Deep 6 AI wins Enterprise & Smart Data category More than 500 companies applied for the SXSW Accelerator, where leading startups from around the world showcase some of the most...
ACRP webinar: How Artificial Intelligence Is Revolutionizing Patient Recruitment April 18, 2017 at 9:00am PT / 12:00pm ET Deep 6 AI is co-presenting an ACRP webinar, “How Artificial Intelligence Is Revolutionizing Patient Recruitment,” on Tuesday, April 18, at 9:00am PT / 12:00pm ET. [vc_row][vc_column width='2/3']Wout Brusselaers, CEO and co-founder...